āagman

Not investment advice. Data and computed figures, for information only.

Zydus Lifesciences Ltd

NSE: ZYDUSLIFEF&O
₹1,140.20
+₹15.50 (+1.38%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹1,11,471 Cr
CMP
₹1,140.20
52-wk High / Low
₹1,232 / 836
P/E
22.9
P/B
4.2
Book Value
₹269.0
Div Yield
0.09%
ROCE
21.0%
ROE
21.2%
Face Value
₹1
D/E
0.46

Price+14.8% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 15 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
4
/ 9
4 of 9 F-score tests passed
Graham Number
₹551
√(22.5 × EPS × book value per share)
ROIC
13.8%
vs 11.2% sector median
Cash flow to profit
0.41
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−770
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
20.8%
ROE × earnings retention ratio
ROE stability
4.8
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.01FII +0.10DII +0.08
Latest quarter vs the previous one
Cash-accrual divergence
6.9%
of assets
Low = accruals track cash flow
Strengths
+Price trades above its 200-day moving average (1.1x)
+Price is within 10% of its 52-week high (-7.5%)
+Annualised volatility of 23.5% is in the low band (≤25%)
+FII holding rose by 3.6pp over the last year
+PE of 22.9x is below the sector median of 45.9x
Watch-outs
−Borrowings are up 411.7% since FY2016 (2442 to 12496)

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales5,1404,3694,5055,5346,2085,2375,2696,5286,5746,1236,8647,5878,017
Expenses3,6343,2233,4033,9034,1243,7763,8824,4024,4854,1075,0485,0336,088
Operating Profit1,5051,1461,1021,6302,0841,4611,3882,1262,0882,0161,8162,5541,929
OPM %29.3%26.2%24.5%29.5%33.6%27.9%26.3%32.6%31.8%32.9%26.5%33.7%24.1%
Other Income215360160636857−1391557526−26388
Interest18920353225327785101130123156
Depreciation180184195205215234229238238302360508555
Profit before tax1,3281,0069471,5501,9001,2711,1841,6721,9211,6871,3531,6601,307
Net Profit1,1348037901,2461,4829201,0261,2441,5211,2391,0231,341990
EPS (₹)10.747.917.8011.7514.119.0610.1711.6414.5812.5110.3612.659.42

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales8,6519,4279,37611,90513,16614,25315,10215,26517,23719,54723,24227,14828,592
Expenses6,8967,0957,4749,07410,17411,45511,75811,92313,37814,16316,18318,67320,276
Operating Profit1,7562,3321,9022,8312,9912,7983,3443,3423,8605,3847,0588,4758,316
OPM %20.3%24.7%20.3%23.8%22.7%19.6%22.1%21.9%22.4%27.5%30.4%31.2%29.1%
Other Income45112127111183−264−1712,581−42229350−7−74
Interest6853459119434216412713081166439510
Depreciation2872923735395996967257137237649161,4081,725
Profit before tax1,4462,0991,6122,3122,3821,4952,2855,0842,5854,8326,0276,6216,007
Net Profit1,1881,9641,5171,8101,8991,2042,1854,6182,0923,9734,6735,1244,593
EPS (₹)11.2418.8914.5317.3518.0611.4920.8443.8319.3738.3644.9750.0944.94

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital102102102102102102102102101101101101—
Reserves4,1495,5976,8588,64210,28410,27312,89016,89717,41519,72923,85227,011—
Borrowings2,6512,4425,2075,4077,8997,9864,5844,2211,1958043,21312,496—
Other Liabilities2,1442,2082,9373,6324,9455,1156,1896,4216,8518,2019,52311,065—
Total Liabilities9,04710,35015,10417,78323,23123,47723,76527,64225,56228,83436,68950,673—
Fixed Assets3,3523,7485,7556,48312,16412,23012,13312,25311,52112,36813,13424,106—
CWIP7989511,5431,5278377427836611,2012,4232,6923,698—
Investments1544164357466747658303,2881,5471,2206,4127,540—
Other Assets4,7435,2357,3719,0289,5569,74010,01911,43911,29412,82214,45115,328—
Total Assets9,04710,35015,10417,78323,23123,47723,76527,64225,56228,83436,68950,673—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity9039941,8941,3129191,2822,5053,2932,1042,6893,2286,7812,117
Cash from Investing Activity−438−465−860−2,872−974−3,977−1,012−8351,1371,178−1,492−8,363−7,895
Cash from Financing Activity−529−351−9352,316521,885−1,094−2,549−868−4,400−1,8101,9955,807
Net Cash Flow−6417899756−3−811399−902,373−534−7541428

Ratios

As of 31 Mar 2026
13 periods
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %17.023.028.016.018.015.011.014.013.015.022.024.021.0
ROE %————————————21.2
EPS (₹)7.8511.2418.8914.5317.3518.0611.4920.8443.8319.3738.3644.9750.09
Book Value (₹)————————————269.0
Face Value (₹)————————————1
P/E————————————22.9
Div Yield %————————————0.09
NPM %11.613.720.616.015.114.28.614.625.912.420.020.118.9
OPM %17.020.025.020.024.023.020.022.022.022.028.030.031.0
D/E0.790.620.430.750.620.760.770.350.250.070.040.130.46
P/B————————————4.2

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+11.0%
5 years+12.0%
3 years+16.0%
TTM+21.0%
Compounded profit growth
10 years+11.0%
5 years+19.0%
3 years+32.0%
TTM+5.0%
Stock price CAGR
10 years+11.0%
5 years+16.0%
3 years+23.0%
Last year+12.0%
Return on equity
10 years20.0%
5 years21.0%
3 years21.0%
Last year21.0%

Shareholding pattern

As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters74.79%74.79%74.79%74.79%74.79%74.88%74.88%74.88%74.98%74.98%75.00%75.00%75.01%
FIIs9.88%9.88%9.88%8.70%8.12%4.41%5.23%2.53%3.42%5.72%7.31%6.95%7.05%
DIIs7.11%7.11%7.11%7.94%9.06%12.90%11.30%12.83%13.51%12.55%10.95%11.20%11.28%
Government0.15%0.15%0.15%0.17%0.13%0.14%0.19%0.08%0.07%0.07%0.05%0.00%0.00%
Public8.07%8.07%8.07%8.40%7.90%7.67%8.40%9.69%8.01%6.66%6.69%6.86%6.66%
No. of shareholders82,78382,78382,78397,9561,18,8231,26,9992,23,3844,08,0173,38,5702,94,3243,71,6194,18,3143,82,067
Change since Jun 2023 (pp)
Promoters +0.22FIIs −2.83DIIs +4.17Public −1.41

Documents

As of 11 Oct 2026
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAnnouncement under Regulation 30 (LODR)-Updates on Joint VentureAnnouncement under Regulation 30 (LODR)-Press Release / Media ReleaseClosure of Trading Window
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTFeb 2026RecordingNov 2025TranscriptNov 2025PPTNov 2025RecordingNov 2025PPT

Corporate actions

As of 24 Jul 2026
24 Jul 2026DIVIDENDDividend - Re 1 Per Share—
25 Jul 2025DIVIDENDDividend - Rs 11 Per Share—
26 Jul 2024DIVIDENDDividend - Rs 3 Per Share—
28 Jul 2023DIVIDENDDividend - Rs 6 Per Share—
28 Jul 2022DIVIDENDDividend - Rs 2.50 Per Share—
28 Jul 2021DIVIDEND Annual General Meeting/Dividend - Rs 3.50 Per Share—
23 Mar 2020DIVIDEND Interim Dividend - Rs 3.50 Per Share—
25 Jul 2019DIVIDEND Annual General Meeting/Dividend - Rs 3.50 Per Share—
31 Jul 2018DIVIDEND Annual General Meeting/Dividend- Rs 3.50 Per Share (Purpose Revised)—
16 Mar 2017DIVIDEND Interim Dividend Rs 3.20 Per Share (Purpose Revised)—
17 Mar 2016DIVIDEND Interim Dividend - Rs 3.20/- Per Share—
6 Oct 2015SPLIT Face Value Split (Sub-Division) - From Rs 5/- Per Share To Re 1/- Per Share5 : 1
30 Jul 2015DIVIDENDAnnual General Meeting/Dividend - Rs 12/- Per Share—
17 Jul 2014DIVIDENDAnnual General Meeting / Dividend - Rs 9/- Per Share—
11 Jun 2013DIVIDENDInterim Dividend Rs 7.50/- Per Equity Share—
26 Jul 2012DIVIDENDAnnual General Meeting/Dividend Rs 7.50 Per Share—
7 Jul 2011DIVIDENDAnnual General Meeting And Dividend Rs.6.25 Per Share—
15 Jul 2010DIVIDENDDividend-Rs.5/- Per Share—
5 Apr 2010BONUSBonus 1: 2—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman